Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Queensland Health
Boehringer Ingelheim
Moodys
McKesson
Harvard Business School
Healthtrust
Medtronic
Cantor Fitzgerald

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,048,859

« Back to Dashboard

Summary for Patent: 6,048,859
Title: Morpholine and thiomorpholine tachykinin receptor antagonists
Abstract:Substituted heterocycles of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis, and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.
Inventor(s): Dorn; Conrad P. (Plainfield, NJ), Finke; Paul E. (Milltown, NJ), Hale; Jeffrey J. (Westfield, NJ), Maccoss; Malcolm (Freehold, NJ), Mills; Sander G. (Woodbridge, NJ), Shah; Shrenik K. (Metuchen, NJ), Chambers; Mark Stuart (Harts, GB), Harrison; Timothy (Great Dunmow, GB), Ladduwahetty; Tamara (Buckhurst Hill, GB), Williams; Brian John (Great Dunnow, GB)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/251,190
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,048,859
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,048,859

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Dow
Cantor Fitzgerald
McKinsey
Federal Trade Commission
UBS
Medtronic
Queensland Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.